MicroCap Rodeo’s Annual Winter Wonderland – Best Ideas Virtual Investor Conference
For Fiscal Year Ending Dec 31, 2021
Sign up today and receive company updates straight to your inbox.
Quarter Ended Sep 30, 2022
Artelo Biosciences, Inc. is a clinical stage pharmaceutical company dedicated to the development and commercialization of proprietary therapeutics that modulate lipid-signaling pathways including the endocannabinoid system. Artelo is advancing a portfolio of broadly applicable product candidates designed to address significant unmet needs in multiple diseases and conditions, including anorexia, cancer, anxiety, pain, neuropathy, and inflammation. Led by proven biopharmaceutical executives collaborating with highly respected researchers and technology experts, the company applies leading edge scientific, regulatory, and commercial discipline to develop high-impact therapies.
Artelo Biosciences, Inc.
505 Lomas Santa Fe Drive
Solana Beach, CA 92075
Crescendo Communications, LLC
American Stock Transfer & Trust Company, LLC
6201 15th Ave
Brooklyn, NY 11219
T: 800-937-5449, 8am-8pm Eastern, M-F